Healthcare & Medical Devices Global On demand · 24-48h

Global Electronic Spirometry Device Market Strategic Research Report

Global Electronic Spirometry Device Market Strategic Researc…
$3,500 USD
Market Research Reports
Strategic Research Report
Global Electronic Spirometry Device Market
$7612025
7.4%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Handheld/Portable, Desktop/Tabletop, PC Connected

By Application: Hospital Respiratory Departments and Pulmonary Function Laboratories, Primary Healthcare Institution, Occupational Health Checkup, Home Chronic Disease Monitoring, Respiratory Drug Development, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: Vitalograph, Medical International Research, ndd Medical Technologies, MGC Diagnostics, Jaeger Medical, SCHILLER, COSMED, SIBEL, Geratherm Respiratory, Medikro, Depisteo, Benson Medical Instruments, Jones Medical Instrument Company, Baxter, Minato Medical Science, CHEST M.I., Inc., The Piston Ltd., Recorders & Medicare Systems Pvt Ltd (RMS), NuvoAir Medical, Fukuda Sangyo, CONTEC Medical Systems, Medcaptain, Guangzhou Red Elephant Medical Technology, Pinyuan Medical (Jiangsu), Zhejiang Keluode Health Technology, Qingdao Meditech Equipment, Jiangsu Yuanyan Medical Equipment

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 184 pages
Market size 2025
$761
Million USD
Forecast CAGR
7.4%
2025-2032
Forecast 2032
$1254.3
Projected
Regiones
5
Asia Pacific · Latin America · MEA · Europe · North America

Vista general

Scope of the Report

The global Electronic Spirometry Device market size is predicted to grow from US$ 761 million in 2025 to US$ 1,240 million in 2032; it is expected to grow at a CAGR of 7.4% from 2026 to 2032.

In 2025, global production of electronic spirometry devices reached 4.32 million units, with an estimated average selling price of US$180 per unit. An electronic spirometry device is an electronic testing device used to measure basic respiratory function, including lung volume and expiratory flow rate. Key indicators include VC/SVC, FVC, FEV1, FEV1/FVC, PEF, and MVV. It is primarily used to assess lung ventilation function, screen for airflow limitation, assist in the diagnosis and follow-up of COPD, asthma, occupational lung diseases, preoperative lung function risk, and manage chronic respiratory diseases. The upstream of the industry chain mainly includes MEMS pressure sensors, flow sensors, ultrasonic transducers, MCUs/processors, PCBAs, batteries, LCD screens, plastic structural parts, disposable mouthpieces, bacterial filters, calibration cylinders, data transmission modules, algorithm software, and cloud platforms; the midstream involves the design, software development, sensor calibration, registration and certification, and assembly and testing of spirometers and spirometers; downstream demand comes from hospitals, clinics, health check centers, occupational health institutions, schools, elderly care facilities, and family health management channels. Gross profit margin is approximately 20%–40%.

Global key Electronic Spirometry Device players cover Vitalograph, Medical International Research, ndd Medical Technologies, MGC Diagnostics, Jaeger Medical, etc.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Electronic Spirometry Device market?

What factors are driving Electronic Spirometry Device market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Electronic Spirometry Device market opportunities vary by end market size?

How does Electronic Spirometry Device break out by Type, by Application?

This report presents a comprehensive overview of the global Electronic Spirometry Device market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Handheld/Portable
  • Desktop/Tabletop
  • PC Connected

Segment by Measurement Technology

  • Differential Pressure/Airflow Sensing
  • Turbine Type
  • Ultrasonic Type
  • Volume Type
  • Disposable Sensor Type

Segment by Application

  • Hospital Respiratory Departments and Pulmonary Function Laboratories
  • Primary Healthcare Institution
  • Occupational Health Checkup
  • Home Chronic Disease Monitoring
  • Respiratory Drug Development
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Electronic Spirometry Device market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Hospital Respiratory Departments and Pulmonary Function Laboratories, Primary Healthcare Institution, Occupational Health Checkup evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Electronic Spirometry Device Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 7.4%
Regional growth momentum
Market share by segment
Key metrics
Base value
$761
2025
Forecast
$1254.3
2032
CAGR
7.4%
2025–2032
Regiones
5
global
Key companies
VitalographMedical International Researchndd Medical TechnologiesMGC DiagnosticsJaeger MedicalSCHILLERCOSMEDSIBEL
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Handheld/PortableDesktop/TabletopPC Connected
By Application
Hospital Respiratory Departments and Pulmonary Function LaboratoriesPrimary Healthcare InstitutionOccupational Health CheckupHome Chronic Disease MonitoringRespiratory Drug DevelopmentOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Handheld/Portable
  • 3.1.3 Desktop/Tabletop
  • 3.1.4 PC Connected
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Hospital Respiratory Departments and Pulmonary Function Laboratories
  • 4.1.3 Primary Healthcare Institution
  • 4.1.4 Occupational Health Checkup
  • 4.1.5 Home Chronic Disease Monitoring
  • 4.1.6 Respiratory Drug Development
  • 4.1.7 Others
  • 4.1.8 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 Vitalograph
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 Medical International Research
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 ndd Medical Technologies
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 MGC Diagnostics
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Jaeger Medical
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 SCHILLER
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 COSMED
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 SIBEL
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 Geratherm Respiratory
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Medikro
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Depisteo
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Benson Medical Instruments
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Jones Medical Instrument Company
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Baxter
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 Minato Medical Science
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 CHEST M.I., Inc.
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 The Piston Ltd.
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Recorders & Medicare Systems Pvt Ltd (RMS)
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
  • 8.19 NuvoAir Medical
  • 8.19.1 Company Overview
  • 8.19.2 Key Products & Segments
  • 8.19.3 Financial Performance (2023–2025)
  • 8.19.4 Business Strategy
  • 8.19.5 SWOT Analysis
  • 8.19.6 Strategic Implications (2026–2032)
  • 8.20 Fukuda Sangyo
  • 8.20.1 Company Overview
  • 8.20.2 Key Products & Segments
  • 8.20.3 Financial Performance (2023–2025)
  • 8.20.4 Business Strategy
  • 8.20.5 SWOT Analysis
  • 8.20.6 Strategic Implications (2026–2032)
  • 8.21 CONTEC Medical Systems
  • 8.21.1 Company Overview
  • 8.21.2 Key Products & Segments
  • 8.21.3 Financial Performance (2023–2025)
  • 8.21.4 Business Strategy
  • 8.21.5 SWOT Analysis
  • 8.21.6 Strategic Implications (2026–2032)
  • 8.22 Medcaptain
  • 8.22.1 Company Overview
  • 8.22.2 Key Products & Segments
  • 8.22.3 Financial Performance (2023–2025)
  • 8.22.4 Business Strategy
  • 8.22.5 SWOT Analysis
  • 8.22.6 Strategic Implications (2026–2032)
  • 8.23 Guangzhou Red Elephant Medical Technology
  • 8.23.1 Company Overview
  • 8.23.2 Key Products & Segments
  • 8.23.3 Financial Performance (2023–2025)
  • 8.23.4 Business Strategy
  • 8.23.5 SWOT Analysis
  • 8.23.6 Strategic Implications (2026–2032)
  • 8.24 Pinyuan Medical (Jiangsu)
  • 8.24.1 Company Overview
  • 8.24.2 Key Products & Segments
  • 8.24.3 Financial Performance (2023–2025)
  • 8.24.4 Business Strategy
  • 8.24.5 SWOT Analysis
  • 8.24.6 Strategic Implications (2026–2032)
  • 8.25 Zhejiang Keluode Health Technology
  • 8.25.1 Company Overview
  • 8.25.2 Key Products & Segments
  • 8.25.3 Financial Performance (2023–2025)
  • 8.25.4 Business Strategy
  • 8.25.5 SWOT Analysis
  • 8.25.6 Strategic Implications (2026–2032)
  • 8.26 Qingdao Meditech Equipment
  • 8.26.1 Company Overview
  • 8.26.2 Key Products & Segments
  • 8.26.3 Financial Performance (2023–2025)
  • 8.26.4 Business Strategy
  • 8.26.5 SWOT Analysis
  • 8.26.6 Strategic Implications (2026–2032)
  • 8.27 Jiangsu Yuanyan Medical Equipment
  • 8.27.1 Company Overview
  • 8.27.2 Key Products & Segments
  • 8.27.3 Financial Performance (2023–2025)
  • 8.27.4 Business Strategy
  • 8.27.5 SWOT Analysis
  • 8.27.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Electronic Spirometry Device market?
The global Electronic Spirometry Device market is estimated at US$ 761 million in 2025 (base year) and is projected to reach US$ 1.24 billion by 2032.
What is the forecast CAGR for the Electronic Spirometry Device market?
The market is expected to grow at a CAGR of 7.4% from 2026 to 2032, expanding from US$ 761 million in 2025 to US$ 1.24 billion in 2032, roughly 1.6 times its base-year value.
What is Electronic Spirometry Device?
In 2025, global production of electronic spirometry devices reached 4.32 million units, with an estimated average selling price of US$180 per unit. An electronic spirometry device is an electronic testing device used to measure basic respiratory function, including lung volume and expiratory flow rate. Key indicators include VC/SVC, FVC, FEV1, FEV1/FVC, PEF, and MVV.
How is the Electronic Spirometry Device market segmented by type?
By type, the market is segmented into Handheld/Portable, Desktop/Tabletop and PC Connected.
What are the key applications of Electronic Spirometry Device?
Key applications covered include Hospital Respiratory Departments and Pulmonary Function Laboratories, Primary Healthcare Institution, Occupational Health Checkup, Home Chronic Disease Monitoring, Respiratory Drug Development and Others.
Which companies are profiled in the Electronic Spirometry Device market report?
Key players profiled include Vitalograph, Medical International Research, ndd Medical Technologies, MGC Diagnostics, Jaeger Medical, SCHILLER, COSMED and SIBEL, among 27 companies covered in total.
What geographies does the Electronic Spirometry Device market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Electronic Spirometry Device?
What factors are driving Electronic Spirometry Device market growth, globally and by region?
Who should buy the Electronic Spirometry Device market report?
The report is intended for manufacturers and solution providers, distributors and end users in Hospital Respiratory Departments and Pulmonary Function Laboratories, Primary Healthcare Institution and Occupational Health Checkup, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Electronic Spirometry Device market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from 3.500,00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.